Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2025-12-17 @ 10:54 PM
Study NCT ID:
NCT04837508
Status:
None
Last Update Posted:
2021-12-10 00:00:00
First Post:
2021-04-06 00:00:00
Brief Title:
A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Sponsor:
Shanghai Miracogen Inc
Organization:
Shanghai Miracogen Inc.